CraigYoshitsuguOkadaMD
Hematology • Portland, ORAssistant Professor, Medicine, Oregon Health and Science University School of Medicine
Are you Dr. Okada?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-6594- Is this information wrong?
Summary
- Dr. Craig Okada, MD is a hematologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Michigan, and California. He is affiliated with OHSU Hospital and Portland HCS.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1993 - 1996- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1990 - 1993
Stanford University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - Present
OR State Medical License 2004 - 2025
MI State Medical License 1998 - 2005- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma Start of enrollment: 2008 May 01
- Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, John K Thomas, Guang Fan, Bill H Chang, Karina Thiel-Klare, Christopher A Eide, Craig Okada, ...> ;Clinical Cancer Research. 2023 Oct 13
- 8 citationsPhase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.Ahmad S Halwani, Carlos Panizo, Iris Isufi, Alex F Herrera, Craig Y Okada, Elizabeth H Cull, Bela Kis, Jorge M Chaves, Nancy L Bartlett, Weiyun Ai, Luis de la Cruz-Mer...> ;Leukemia & Lymphoma. 2022 Apr 1
- 1 citationsA novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemia.Vikram Raghunathan, Guang Fan, Adam Kittai, Craig Okada, Alexey V. Danilov, Stephen E. Spurgeon> ;European Journal of Haematology. 2021 Feb 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Portland HCSPortland, Oregon
OHSU HospitalPortland, Oregon
